phenobarbital has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 2 studies
Phenobarbital: A barbituric acid derivative that acts as a nonselective central nervous system depressant. It potentiates GAMMA-AMINOBUTYRIC ACID action on GABA-A RECEPTORS, and modulates chloride currents through receptor channels. It also inhibits glutamate induced depolarizations.
phenobarbital : A member of the class of barbiturates, the structure of which is that of barbituric acid substituted at C-5 by ethyl and phenyl groups.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mendes, DCC | 1 |
| Filho, CMCC | 1 |
| Garcia, N | 1 |
| Ricci, MD | 1 |
| Soares, JM | 1 |
| Carvalho, KC | 1 |
| Baracat, EC | 1 |
| Stewart, DA | 1 |
| Winnike, JH | 1 |
| McRitchie, SL | 1 |
| Clark, RF | 1 |
| Pathmasiri, WW | 1 |
| Sumner, SJ | 1 |
2 other studies available for phenobarbital and ER-Negative PR-Negative HER2-Negative Breast Cancer
| Article | Year |
|---|---|
Could be FOXO3a, miR-96-5p and miR-182-5p useful for Brazilian women with luminal A and triple negative breast cancers prognosis and target therapy?
Topics: Biomarkers, Tumor; Brazil; Breast Neoplasms; Carcinogenesis; Female; Gene Expression Profiling; Gene | 2023 |
Metabolomics Analysis of Hormone-Responsive and Triple-Negative Breast Cancer Cell Responses to Paclitaxel Identify Key Metabolic Differences.
Topics: Amino Acids; Carbohydrate Metabolism; Cell Line, Tumor; Female; Hormones; Humans; Lipid Metabolism; | 2016 |